Discussion of the paper "Adaptive dose-ranging designs".
Burman
Carl-Fredrik
CF
Biostatistics, AstraZeneca R&D, Mölndal, Sweden. carl-fredrik.burman@astrazeneca.com
D002986:Clinical Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004345:Drug Industry; D006801:Humans; D012107:Research Design